Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170M
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
95.1M
-
Shares change
-
+2.84M
-
Total reported value, excl. options
-
$2.15B
-
Value change
-
+$59.7M
-
Put/Call ratio
-
0.08
-
Number of buys
-
73
-
Number of sells
-
-80
-
Price
-
$22.59
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q2 2014
203 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q2 2014.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95.1M shares
of 170M outstanding shares and own 55.88% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (20.5M shares), FMR LLC (14.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.96M shares), VANGUARD GROUP INC (4.83M shares), Viking Global Investors LP (4.76M shares), JENNISON ASSOCIATES LLC (3.05M shares), BlackRock Fund Advisors (2.94M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.31M shares), BlackRock Institutional Trust Company, N.A. (2.24M shares), and FRANKLIN RESOURCES INC (2.12M shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.